<< Provident Healthcare Partners to provide strategic advisory services for NCIS' growth in oncology management field | Research journal to host a webinar on apoptotic signalling in normal and cancer cell biology >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Bahasa | Русский | Svenska | Polski

Ranaz Corporation to raise funds through private placement

Published on August 29, 2009 at 2:23 AM · No Comments

Ranaz Corporation ("Ranaz") (TSXV: RNZ), a company specialized in the manufacturing and marketing of protein and dietary supplements, announces that it intends to raise $675,000 through a non-brokered private placement of units. Each unit, priced at $0.065 will consist of one common share of Ranaz and one share purchase warrant (exercise price: $0.10), which will expire five years from their issue date. A maximum of 20,769,228 common shares of Ranaz may be issued under this private placement (assuming the exercise of all warrants).

An insider of Ranaz, Fiducie Vanquish, will subscribe for more than 25% of the private placement.

Closing of this private placement will be subject to the approval of the TSX Venture Exchange.

Source: RANAZ CORPORATION

Posted in:

Tags: ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading